Effect of Growth Hormone in Children With Growth Hormone Deficiency
Public ClinicalTrials.gov record NCT00262249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of Growth Hormone in Children With Growth Hormone Deficiency and Idiopathic Short Stature
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). The purpose of the trial is to compare the effect of Norditropin® using different dosing regimens in children suspected of growth hormone deficiency.
Study identification
- NCT ID
- NCT00262249
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 173 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Years to 15 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2000 (Type not available)
- Primary completion
- May 2004 (Actual)
- Completion
- May 2004 (Actual)
- Last update posted
- Jan 18, 2017
2000 – 2004
United States locations
- U.S. sites
- 40
- U.S. states
- 22
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Los Angeles | California | 90027 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90095 | — |
| Novo Nordisk Investigational Site | Sacramento | California | 95817 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92093 | — |
| Novo Nordisk Investigational Site | Stanford | California | 94305-5208 | — |
| Novo Nordisk Investigational Site | New Haven | Connecticut | 06520 | — |
| Novo Nordisk Investigational Site | Gainesville | Florida | 32608 | — |
| Novo Nordisk Investigational Site | St. Petersburg | Florida | 33701 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | Skokie | Illinois | 60077 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46202 | — |
| Novo Nordisk Investigational Site | Iowa City | Iowa | 52242 | — |
| Novo Nordisk Investigational Site | Shreveport | Louisiana | 71130-3932 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21287 | — |
| Novo Nordisk Investigational Site | Springfield | Massachusetts | 01107 | — |
| Novo Nordisk Investigational Site | Worcester | Massachusetts | 01655 | — |
| Novo Nordisk Investigational Site | Kalamazoo | Michigan | 49008 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55416 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55455 | — |
| Novo Nordisk Investigational Site | Kansas City | Missouri | 64108 | — |
| Novo Nordisk Investigational Site | Morristown | New Jersey | 07962 | — |
| Novo Nordisk Investigational Site | Brooklyn | New York | 11219 | — |
| Novo Nordisk Investigational Site | Buffalo | New York | 14222 | — |
| Novo Nordisk Investigational Site | New Hyde Park | New York | 11042 | — |
| Novo Nordisk Investigational Site | New York | New York | 10029 | — |
| Novo Nordisk Investigational Site | Stony Brook | New York | 11794 | — |
| Novo Nordisk Investigational Site | The Bronx | New York | 10467 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45229 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44106 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44195 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43205 | — |
| Novo Nordisk Investigational Site | Portland | Oregon | 97239 | — |
| Novo Nordisk Investigational Site | Hershey | Pennsylvania | 17033 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Novo Nordisk Investigational Site | Charleston | South Carolina | 29425 | — |
| Novo Nordisk Investigational Site | Columbia | South Carolina | 29203 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38103 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78284 | — |
| Novo Nordisk Investigational Site | Seattle | Washington | 98105 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53226-0509 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00262249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2017 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00262249 live on ClinicalTrials.gov.